Perkins Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-233
| Closed | -$4K | – | 119 |
|
|
2019
Q3 | $4K | Sell |
233
-19,659
| -99% | -$337K | ﹤0.01% | 112 |
|
|
2019
Q2 | $487K | Sell |
19,892
-1,018
| -5% | -$24.9K | 0.34% | 81 |
|
|
2019
Q1 | $753K | Buy |
20,910
+18,122
| +650% | +$653K | 0.5% | 63 |
|
|
2018
Q4 | $101K | Sell |
2,788
-5,794
| -68% | -$210K | 0.08% | 115 |
|
|
2018
Q3 | $1.34M | Buy |
8,582
+1,885
| +28% | +$294K | 0.8% | 42 |
|
|
2018
Q2 | $894K | Buy |
6,697
+273
| +4% | +$36.4K | 0.64% | 53 |
|
|
2018
Q1 | $1.59M | Sell |
6,424
-174
| -3% | -$43.1K | 1.43% | 14 |
|
|
2017
Q4 | $1.83M | Buy |
6,598
+1,220
| +23% | +$339K | 1.76% | 10 |
|
|
2017
Q3 | $2.18M | Sell |
5,378
-144
| -3% | -$58.3K | 2.28% | 7 |
|
|
2017
Q2 | $3.27M | Sell |
5,522
-57
| -1% | -$33.8K | 3.63% | 5 |
|
|
2017
Q1 | $3.43M | Sell |
5,579
-178
| -3% | -$109K | 3.54% | 5 |
|
|
2016
Q4 | $1.17M | Sell |
5,757
-7
| -0.1% | -$1.42K | 1.28% | 22 |
|
|
2016
Q3 | $1.51M | Buy |
5,764
+1,889
| +49% | +$496K | 1.51% | 17 |
|
|
2016
Q2 | $1.16M | Buy |
3,875
+2,642
| +214% | +$789K | 1.33% | 23 |
|
|
2016
Q1 | $525K | Hold |
1,233
| – | – | 0.66% | 54 |
|
|
2015
Q4 | $610K | Buy |
+1,233
| New | +$610K | 0.65% | 53 |
|
|
2014
Q2 | – | Sell |
-514
| Closed | -$1.16M | – | 146 |
|
|
2014
Q1 | $1.16M | Sell |
514
-31
| -6% | -$70.1K | 0.82% | 46 |
|
|
2013
Q4 | $1.13M | Buy |
+545
| New | +$1.13M | 0.76% | 48 |
|